Patents by Inventor Masaki Miyazaki
Masaki Miyazaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11943398Abstract: A maintenance support system includes a network interface, a memory, and a processor configured to, upon receipt of first information indicating a status of a first apparatus via the network interface, store the first information in the memory, upon receipt of second information indicating a status of a second apparatus via the network interface, store the second information in the memory, and determine a priority of on-site maintenance between the first and second apparatuses based on the first and second information stored in the memory.Type: GrantFiled: April 27, 2023Date of Patent: March 26, 2024Assignee: Toshiba Tec Kabushiki KaishaInventors: Sou Miyazaki, Hiroyo Tanaka, Kazuhiro Ogura, Masaki Narahashi, Satoshi Oyama
-
Patent number: 11943414Abstract: An image processing apparatus includes a display device and a processor. The processor is configured to generate a first screen for display on the display device and on which one of a plurality of malfunctioning part candidates of the image processing apparatus and one of a plurality of timings at which a particular sound was output by the image processing apparatus that malfunctioned, are selectable, when a first malfunctioning part candidate and a first timing are selected on the first screen, generate a second screen for display on the display device and on which one or more reference sounds corresponding to the particular sound are selectable, and when one of the reference sounds is selected on the second screen, generate error information indicating the first malfunctioning part candidate and the selected reference sound.Type: GrantFiled: April 13, 2023Date of Patent: March 26, 2024Assignee: Toshiba Tec Kabushiki KaishaInventors: Sou Miyazaki, Hiroyo Tanaka, Kazuhiro Ogura, Masaki Narahashi, Satoshi Oyama, Tatsuya Inagi
-
Publication number: 20220106324Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.Type: ApplicationFiled: April 19, 2021Publication date: April 7, 2022Inventors: Yuuichi SUGIMOTO, Kouichi UOTO, Takanori WAKABAYASHI, Masaki MIYAZAKI, Masaki SETOGUCHI, Toru TANIGUCHI, Keisuke YOSHIDA, Akitake YAMAGUCHI, Shoko YOSHIDA
-
Publication number: 20140121196Abstract: A compound that inhibits interaction between, murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.Type: ApplicationFiled: November 14, 2013Publication date: May 1, 2014Applicant: Daiichi Sankyo Company, LimitedInventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
-
Patent number: 8629133Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.Type: GrantFiled: March 9, 2012Date of Patent: January 14, 2014Assignee: Daiichi Sankyo Company, LimitedInventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
-
Publication number: 20130165424Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.Type: ApplicationFiled: March 9, 2012Publication date: June 27, 2013Inventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
-
Patent number: 8404691Abstract: There is provided compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. Compounds include imidazothiazole derivatives that can inhibit interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity.Type: GrantFiled: July 15, 2011Date of Patent: March 26, 2013Assignee: Daiichi Sankyo Company, LimitedInventors: Kouichi Uoto, Yuuichi Sugimoto, Hiroyuki Naito, Masaki Miyazaki, Keisuke Yoshida, Masashi Aonuma
-
Publication number: 20120264738Abstract: A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.Type: ApplicationFiled: March 9, 2012Publication date: October 18, 2012Inventors: Yuuichi Sugimoto, Kouichi Uoto, Takanori Wakabayashi, Masaki Miyazaki, Masaki Setoguchi, Toru Taniguchi, Keisuke Yoshida, Akitake Yamaguchi, Shoko Yoshida
-
Patent number: 8290869Abstract: Automated teller machine systems and methods for reducing system development efforts by financial institutions and for providing a financial transaction system that is adapted for using one or more common ATMs. In addition, systems and methods to simplify settlement processing of transactions based on ATMs of each financial institution. ATMs and center systems of financial institutions are dissociated from each other, and a relay center intervenes between them.Type: GrantFiled: May 22, 2008Date of Patent: October 16, 2012Assignee: International Business Machines CorporationInventors: Masaki Miyazaki, Akira Hasegawa
-
Publication number: 20110301176Abstract: There is provided compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. Compounds include imidazothiazole derivatives that can inhibit interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity.Type: ApplicationFiled: July 15, 2011Publication date: December 8, 2011Inventors: Kouichi Uoto, Yuuichi Sugimoto, Hiroyuki Naito, Masaki Miyazaki, Keisuke Yoshida, Masashi Aonuma
-
Patent number: 7744787Abstract: In monitoring anomalies in a measurement process comprising a main measurement process Sa which performs a measurement by forward rotating a screw 3 having a back-flow prevention valve 2 installed on the tip and a post-measurement process which performs a post-measurement process Sb for closing said back-flow prevention valve 2 after this main measurement process Sa ends, after said post-measurement process Sb ends, an injection process Si wherein said screw 3 is put in a freely-rotatable state and moved forward is performed, the amount of rotation Rd of said screw 3 since the start of this injection process Si is detected, and if the detected amount of rotation Rd exceeds at least a preset amount Rs, an anomaly processing (S9) is performed.Type: GrantFiled: September 5, 2007Date of Patent: June 29, 2010Assignee: Nissei Plastic Industrial Co., Ltd.Inventors: Toshimi Kato, Takashi Hakoda, Masaki Miyazaki
-
Patent number: 7678303Abstract: A measurement method including a main measurement process Sa in which measurement is performed by rotating a screw in the forward direction with a back-flow prevention valve installed on its tip and a post-measurement process Sb which is performed by rotating the screw in a reverse direction after the main measurement process Sa is finished, the post-measurement process Sb being performed after completing the main measurement process Sa, in which the screw is moved forward in a free rotational state, the rotational state of the screw during the forward movement being monitored, and if the rotation of screw comes to a halt, the screw is rotated in a reverse direction by a specified amount of rotation.Type: GrantFiled: May 26, 2006Date of Patent: March 16, 2010Assignee: Nissei Plastic Industrial Co., Ltd.Inventors: Haruo Okada, Toshimi Kato, Masaki Miyazaki, Hiroo Kudo
-
Publication number: 20090312310Abstract: There is provided a novel compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. The present invention provides an imidazothiazole derivative represented by the following formula (1) having various substituents that inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity: wherein R1, R2, R3, R4, and R5 in the formula (1) each has the same meaning as defined in the specification.Type: ApplicationFiled: June 11, 2009Publication date: December 17, 2009Inventors: Haruko Kawato, Masaki Miyazaki, Yuuichi Sugimoto, Hiroyuki Naito, Tooru Okayama, Tsunehiko Soga, Kouichi Uoto
-
Publication number: 20080272190Abstract: Automated teller machine systems and methods for reducing system development efforts by financial institutions and for providing a financial transaction system that is adapted for using one or more common ATMs. In addition, systems and methods to simplify settlement processing of transactions based on ATMs of each financial institution. ATMs and center systems of financial institutions are dissociated from each other, and a relay center intervenes between them.Type: ApplicationFiled: May 22, 2008Publication date: November 6, 2008Inventors: Masaki Miyazaki, Akira Hasegawa
-
Patent number: 7401051Abstract: Automated teller machine systems and methods for reducing system development efforts by financial institutions and for providing a financial transaction system that is adapted for using one or more common ATMs. In addition, systems and methods to simplify settlement processing of transactions based on ATMs of each financial institution. ATMs and center systems of financial institutions are dissociated from each other, and a relay center intervenes between them.Type: GrantFiled: April 5, 2001Date of Patent: July 15, 2008Assignee: International Business Machines CorporationInventors: Masaki Miyazaki, Akira Hasegawa
-
Publication number: 20080065356Abstract: In monitoring anomalies in a measurement process comprising a main measurement process Sa which performs a measurement by forward rotating a screw 3 having a back-flow prevention valve 2 installed on the tip and a post-measurement process which performs a post-measurement process Sb for closing said back-flow prevention valve 2 after this main measurement process Sa ends, after said post-measurement process Sb ends, an injection process Si wherein said screw 3 is put in a freely-rotatable state and moved forward is performed, the amount of rotation Rd of said screw 3 since the start of this injection process Si is detected, and if the detected amount of rotation Rd exceeds at least a preset amount Rs, an anomaly processing (S9) is performed.Type: ApplicationFiled: September 5, 2007Publication date: March 13, 2008Inventors: Toshimi Kato, Takashi Hakoda, Masaki Miyazaki
-
Patent number: 7189278Abstract: A method for producing semiconductor or metal particles comprises the steps of: storing a semiconductor or metal melt in a crucible having a nozzle; supplying a gas comprising at least one selected from the group consisting of He, Ne, Ar, Kr and Xe into the crucible such that the pressure of the supplied gas in a space over the melt in the crucible is higher than the pressure of a gaseous phase into which the melt is dropped; dropping the melt from the nozzle into the gaseous phase by the pressure of the gas to form liquid particles; and solidifying the liquid particles in the gaseous phase to obtain semiconductor or metal particles. The crucible comprises at least one selected from the group consisting of hexagonal BN, cubic BN, Si3N4, TiB2, ZrB2, zirconia and stabilized zirconia at least near the nozzle.Type: GrantFiled: April 18, 2003Date of Patent: March 13, 2007Assignee: Clean Venture 21 CorporationInventors: Kenji Kato, Yukio Yamaguchi, Seiichi Isomae, Masaki Miyazaki
-
Publication number: 20040007790Abstract: A method for producing semiconductor or metal particles comprises the steps of: storing a semiconductor or metal melt in a crucible having a nozzle; supplying a gas comprising at least one selected from the group consisting of He, Ne, Ar, Kr and Xe into the crucible such that the pressure of the supplied gas in a space over the melt in the crucible is higher than the pressure of a gaseous phase into which the melt is dropped; dropping the melt from the nozzle into the gaseous phase by the pressure of the gas to form liquid particles; and solidifying the liquid particles in the gaseous phase to obtain semiconductor or metal particles. The crucible comprises at least one selected from the group consisting of hexagonal BN, cubic BN, Si3N4, TiB2, ZrB2, zirconia and stabilized zirconia at least near the nozzle.Type: ApplicationFiled: April 18, 2003Publication date: January 15, 2004Inventors: Kenji Kato, Yukio Yamaguchi, Seiichi Isomae, Masaki Miyazaki
-
Patent number: D767398Type: GrantFiled: December 18, 2014Date of Patent: September 27, 2016Assignee: HISAMITSU PHARMACEUTICAL CO., LTD.Inventors: Masaki Miyazaki, Shigeo Kusumi
-
Patent number: D774400Type: GrantFiled: June 17, 2015Date of Patent: December 20, 2016Assignee: HISAMITSU PHARMACEUTICAL CO., INC.Inventors: Masaki Miyazaki, Shigeo Kusumi